Eloxx Pharmaceuticals Insider Trades
NASDAQ: ELOXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Eloxx Pharmaceuticals insider activity
Over the last 12 months, Eloxx Pharmaceuticals insiders reported 8 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Domicilium Real Estate Fund III LP (10% Owner) reporting a transaction in 238,422 shares on Jun 10, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ELOX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ELOX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 10, 2026 | Domicilium Real Estate Fund III LP10% Owner | other | 361,578 | — | Form 4 |
| Jun 10, 2026 | Domicilium Real Estate Fund III LP10% Owner | other | 238,422 | — | Form 4 |
| May 27, 2026 | Coastlands Capital LP10% Owner | other | 1,250,000 | — | Form 4 |
| May 27, 2026 | Domicilium Real Estate Fund III LP10% Owner | other | 113,636 | — | Form 4 |
| Feb 28, 2026 | Aggarwal SumitPresident and CEO | Option exercise | 260,946 | $39.14K | Form 4 |
| Jan 24, 2026 | Walts Alan EdmundDirector | Option exercise | 1,875 | — | Form 4 |
| Jan 24, 2026 | Aggarwal SumitPresident and CEO | Option exercise | 15,000 | — | Form 4 |
| Jan 24, 2026 | Rubin Steven DDirector | Option exercise | 1,875 | — | Form 4 |
| Sep 19, 2025 | Aggarwal SumitPresident and CEO | Award | 1,000,000 | — | Form 4 |
| Aug 14, 2025 | Aggarwal SumitPresident and CEO | Option exercise | 196,880 | $19.69 | Form 4 |
| Jan 24, 2025 | Androski LindsayDirector | Option exercise | 3,750 | — | Form 4 |
| Jan 24, 2025 | Rubin Steven DDirector | Option exercise | 3,750 | — | Form 4 |
| Jan 24, 2025 | Aggarwal SumitDirector | Option exercise | 30,000 | — | Form 4 |
| Jan 24, 2025 | Walts Alan EdmundDirector | Option exercise | 3,750 | — | Form 4 |
| Oct 16, 2024 | Aggarwal SumitPRESIDENT AND CEO | Award | 165,000 | — | Form 4 |
| Oct 16, 2024 | Rubin Steven DDirector | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Walts Alan EdmundDirector | Award | 12,000 | — | Form 4 |
| Oct 16, 2024 | Androski LindsayDirector | Award | 12,000 | — | Form 4 |
| Dec 1, 2021 | Walts Alan EdmundDirector | Option exercise | 37,695 | — | Form 4 |
| Dec 1, 2021 | Aggarwal SumitPRESIDENT AND CEO | Tax withholding | 81,933 | $58.99K | Form 4 |
| Dec 1, 2021 | Aggarwal SumitPRESIDENT AND CEO | Option exercise | 279,158 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4